![]() Featured News September 04, 2014
Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting
August 06, 2014
Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting
| Welcome to Med BioGene
On April 15, 2011, Precision Therapeutics, Inc. and Med BioGene closed their commercialization agreement. The agreement provides to Precision exclusive global rights to develop and commercialize GeneFx Lung. For more information on Precision Therapeutics, please see www.precisiontherapeutics.com. |
|
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer